feed,title,long_url,short_url
Benzinga,"Schizophrenia Player BioXcel's Drug Faces Funding Headwinds, Analyst Downgrades Stock",https://benzinga.com/general/biotech/23/10/35113682/schizophrenia-player-bioxcels-drug-faces-funding-headwinds-analyst-downgrades-stock,https://da.gd/1dpfmj
